NCT04578873View on ClinicalTrials.gov

Phase 1 Oral QPX7831 SAD and MAD in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

April 13, 2021

Primary Completion Date

August 30, 2022

Study Completion Date

August 30, 2022

Conditions
Bacterial Infections
Interventions
DRUG

QPX7831

capsule

DRUG

placebo comparator

oral matched placebo capsule

Trial Locations (2)

90630

Altasciences, Cypress

Unknown

CMAX, Adelaide

All Listed Sponsors
collaborator

Biomedical Advanced Research and Development Authority

FED

lead

Qpex Biopharma, Inc.

INDUSTRY